ESMO 2023 Videos

Exploring Bladder Cancer Innovations: A Deep Dive into ESMO 2023 - Morgan Rouprêt

December 13, 2023

Details

Chinese Subgroup Analysis Reveals Both Similar and Distinct Responses to Novel Darolutamide Combination Therapy - Yao Zhu

December 11, 2023

Details

Bispecific Antibody Inhibiting PD-1 and CTLA-4 Demonstrates Effectiveness Against Advanced Kidney Cancer in Early Study - Martin Voss

November 22, 2023

Details

Gemcitabine, Cisplatin and Immunotherapy: A Promising Mix for Advanced Bladder Cancer - Guru Sonpavde & Matthew Galsky

November 21, 2023

Details

Parsing the Evidence from the EMBARK Trial on a Promising New Drug Regimen in High-Risk Non-Metastatic Hormone-Sensitive Prostate Cancer - Matthew Cooperberg

November 21, 2023

Details

Novel Antibody-Drug Conjugate Combination Yields High Response in Advanced Bladder Cancer - Guru Sonpavde & Bradley McGregor

November 21, 2023

Details

Multimodal AI Informing Treatment Decisions in Advanced Prostate Cancer - Gerhardt Attard

November 20, 2023

Details

ENZA-p Trial Shows Promise for Enzalutamide-Lutetium Combination in Prostate Cancer - Louise Emmett

November 20, 2023

Details

Novel STEAP1 Targeted BiTE Therapy Demonstrates Early Efficacy in Phase 1 Trial - William Kevin Kelly

November 17, 2023

Details

Shifting Clinical Trial Design Towards Improving Patient Enrollment - Michael Morris

November 17, 2023

Details

AMG 509's Potential in Prostate Cancer Therapy - Michael Morris

November 17, 2023

Details

Targeted Kidney Cancer Therapy Sparks Hope For Tough-To-Treat Patients - Dan George

November 16, 2023

Details

Attacking Androgen Receptor From Two Sides: The Potential of a Novel Drug Duo in Prostate Cancer - Christos Kyriakopoulos

November 15, 2023

Details

For Bladder Cancer Patients, New Hope From Immunotherapy Innovations from ESMO 2023 - Petros Grivas

November 14, 2023

Details

The EV-302 Study and the Implications for Metastatic Bladder Cancer Care - Cora Sternberg

November 13, 2023

Details

Innovative Prostate Cancer Therapy Insights Unveiled in ESMO 2023 Meeting - Alan Bryce

November 10, 2023

Details

The LITESPARK-013 Trial and Belzutifan's Optimal Dose for Treating Metastatic Renal Cell Carcinoma - Neeraj Agarwal

November 10, 2023

Details

The ARASTEP Study: Evaluating the Treatment of Biochemically Recurrent Disease in nmHSPC Patients- Alicia Morgans

November 10, 2023

Details

PSMAfore Study Unveils Game-Changing Results for Prostate Cancer Treatment - Oliver Sartor

October 23, 2023

Details

Masofaniten in Advanced Prostate Cancer: A Phase II Trial and Promising Insights - Mark Markowski

October 16, 2023

Details